台股 » 個股 » 生展 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

生展

(8279)
  • 股價
    155.0
  • 漲跌
    ▲4.5
  • 漲幅
    +2.99%
  • 成交量
    13
  • 產業
    上櫃 生技醫療類股
  • 68人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
生展 (8279)籌碼相關-永豐金-中和 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

永豐金-中和 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/03/291158.0000.00157.501118.79%
2024/01/080.1151.5000.00152.000.1100.48%
2023/12/190.1150.5000.00152.500.1100.50%
2023/10/1200.001161.50163.00-110-9.62%
2023/10/110.1163.0000.00161.500.1100.48%
2023/09/110164.0000.00166.000170.03%
2023/09/080.1165.0000.00168.000.1170.28%
2023/09/060.1165.0000.00168.000.1180.27%
2023/06/161172.5000.00173.001521.90%
2023/04/1900.002182.00183.50-249-4.07%
2023/03/1500.003169.50169.50-362-4.79%
2023/03/1000.003169.00171.00-365-4.59%
2023/01/0600.001162.00163.00-169-1.44%
2022/12/261174.0000.00171.001691.44%
2022/10/3100.001137.00137.00-199-1.00%
2022/10/271143.0000.00140.0011001.00%
2022/08/2200.004174.50170.00-481-4.89%
2022/08/1200.0010153.00154.00-1063-15.81%
2021/08/16589.5000.0089.6054211.71%
2021/08/12591.5000.0092.5054111.91%
2021/01/251098.8000.0099.50104820.62%
2021/01/215100.0000.00100.0054411.27%
2020/08/1926134.9026135.87135.0001150.00%
2020/04/1500.00195.7097.20-192-1.08%
2020/04/1400.00994.8496.00-991-9.80%
2020/04/1300.001095.6895.90-1091-10.94%
2020/03/1700.00180.8081.70-182-1.21%
2020/03/16590.10593.6087.500800.00%
2020/03/13590.8800.0093.905806.25%
2020/03/095116.5000.00116.505707.10%
2019/12/3100.0010117.15117.50-1068-14.60%
2019/12/1200.002.6116.00115.50-2.669-3.65%
2019/12/035117.5000.00117.505677.40%
2019/12/025118.002120.50118.503674.44%
2019/11/221123.0000.00122.501641.55%
2019/11/1800.0010114.80115.00-1060-16.44%
2019/09/162141.5000.00141.5021131.76%
2019/09/122142.0000.00141.5021131.76%
2019/09/1000.005141.70142.00-5113-4.40%
2019/09/0400.005142.50143.50-5114-4.38%
2019/08/135136.0000.00136.5051034.84%
2019/08/121141.0000.00139.5011020.98%
2019/08/062144.5000.00147.002962.07%
2019/08/022147.0000.00150.002962.08%
2019/07/305152.0000.00151.005925.38%
2019/07/2910157.0000.00159.50108611.61%
2019/07/255154.0000.00153.505865.77%
2019/07/1900.0021147.29148.00-2178-26.71%
2019/07/161154.0000.00154.501721.38%
2019/06/1100.005124.50125.00-550-9.94%
2019/03/293113.0000.00113.003506.00%
2019/03/0500.000.3111.50112.00-0.332-0.93%
2018/11/1400.00393.6793.50-344-6.73%
2018/09/14792.8900.0093.0075312.99%
2018/09/1100.00292.7593.00-255-3.63%
2018/08/2800.001100.00100.00-167-1.47%
2018/06/2200.007145.71145.50-7275-2.54%
2018/06/0500.005158.00153.50-5296-1.69%
2018/05/295146.0000.00145.0052971.68%
2018/05/2500.006147.25145.50-6299-2.01%
2018/05/2400.009147.17149.00-9303-2.96%
2018/04/2600.001161.00156.50-1366-0.27%
2018/04/2400.001165.50161.50-1374-0.27%
2018/04/232179.7500.00172.0023640.55%
2018/04/1000.003166.50155.00-3332-0.90%
2018/03/311156.006153.33153.50-5288-1.73%
2018/03/307152.1410154.00151.00-3282-1.06%
2018/03/2911148.5900.00147.50112704.06%
2018/03/273143.0000.00141.0032621.14%
2018/02/276136.5000.00136.0063131.91%
2018/02/269134.0000.00135.5093142.86%
2018/02/125136.001139.50136.0043011.33%
2018/02/0817159.0900.00155.50172935.79%
2018/02/0700.008169.38165.00-8298-2.68%
2018/02/068163.132169.00162.5063071.95%
2018/02/0500.005173.00175.50-5318-1.57%
2018/01/301178.0000.00177.0013240.31%
2018/01/2900.001182.00183.00-1325-0.31%
2018/01/261181.0000.00179.5013210.31%
2018/01/225172.501171.50172.5043131.27%
2018/01/173165.5000.00165.5032931.02%
2018/01/161169.0000.00168.0012940.34%
2018/01/0500.0025156.14157.50-25269-9.29%
〈國光生展望〉子公司安特羅腸病毒三期臨床入尾聲 明年展開IPOAnue鉅亨-2023/12/26
〈國光生展望〉流感疫苗申請巴西藥證+破傷風切新市場 外銷業績拚成長Anue鉅亨-2023/12/26
〈聯合再生展望〉洪傳獻:TOPCon技術明年成主流 獲利表現佳Anue鉅亨-2023/10/16
生展 相關文章